ABACAVIR, LAMIVUDINE AND ZIDOVUDINE
NDC 68180-286, ABACAVIR , LAMIVUDINE AND ZIDOVUDINE, tablet, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 68180-286
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202912
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68180-286 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAMIVUDINE150 mg/1
- ZIDOVUDINE300 mg/1
- ABACAVIR SULFATE300 mg/1
Pharmacologic classes
Cytochrome P450 1A1 Inhibitors [MoA]; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/f5f7c0d9-a247-4308-8269-32accc490ea6
Use it
Look up 68180-286 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68180-286 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68180-286. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.